Log In
BCIQ
Print this Print this
 

SynCon MERS DNA vaccine (GLS-5300, INO-4500)

  Manage Alerts
Collapse Summary General Information
Company Inovio Pharmaceuticals Inc.
DescriptionSynthetic DNA vaccine targeting Middle East respiratory syndrome (MERS) antigens
Molecular Target
Mechanism of ActionVaccine
Therapeutic ModalityPreventive vaccine: DNA vaccine
Latest Stage of DevelopmentPhase I
Standard IndicationCoronavirus
Indication DetailsVaccinate against Middle East respiratory syndrome coronavirus (MERS-CoV) infection
Regulatory Designation
PartnerGeneOne Life Science Inc.

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
Total Number of DealsTotal Deal ValueTotal Upfront CashTotal Milestone Payments

1

0

0

0


 Deals Details
DateCompanies InvolvedDeal HeadlineTotal Deal ValueTotal Upfront CashTotal Milestone

05/27/2015

Undisclosed

0

Undisclosed

Get a free BioCentury trial today